Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Hypothesis: In selected patients external hyperthermia will be used in combination with
intravesical Mitomycin-C (MMC) to treat recurrent transitional cell carcinoma (TCC) of the
bladder after local resection and standard adjuvant therapy and thus prevent or delay
recurrence and the need for radical cystectomy.